Columbia Licenses Novel 3-D Organ and Tumor Segmentation Software to Varian Medical Systems

News   May 17, 2013

 
Columbia Licenses Novel 3-D Organ and Tumor Segmentation Software to Varian Medical Systems
 
 
 

RELATED ARTICLES

Synthetic Auxin Reveals Importance In Plants

News

A new synthetic hormone promises to tease apart the many different roles of the plant hormone auxin and could lead to a new way to ripen fruit.

READ MORE

QIAGEN Receives FDA Clearance for JAK2 Diagnostic Test

News

Expanded use of ipsogen test provides diagnostic testing needs for all myeloproliferative neoplasms in line with the latest WHO guidelines.

READ MORE

Cobra Biologics Awarded £2.6m ($3.4m USD) from Innovate UK

News

Capital infrastructure investment to embed and secure clinical and commercial viral vector manufacturing capability within the UK. Award made as part of UK’s Innovation Agency’s Industrial Strategy boost for UK medicines with £70m of funding to help develop new treatments.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE